Truth About Weight Loss Drugs

Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.
Analysis finds that after 2 years GLP-1 drugs for weight loss don’t justify their price
Study of those who started taking blockbuster weight loss drugs in 2021 suggests patients need support services, not just the medications.
Big Food Is Learning to Love Weight-Loss Drugs
A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present just as many opportunities as pitfalls. People taking the drugs do indeed eat less—especially indulgent treats.
Weight-loss drugs didn't curb health costs within two years
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims shared with Reuters.
New York City Utterly Screwed Up Insurance for Employees Taking GLP-1 Weight Loss Drugs
After insurance for New York City employees began covering GLP-1 weight-loss injectables, more than 1,000 city workers and their dependents began using the drugs — and now, they're being told that coverage was accidental.
How Ozempic, GLP-1 Weight Loss Drugs Affect the Brain to Curb Substance Misuse
A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like Ozempic. These medications interact with a part of the brain that can help suppress appetite,
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds
Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and 2023, a new tally finds. "In contrast, there was a 25.6% decrease in patients undergoing metabolic bariatric surgery" during the same time period,
The Truth About Weight Loss Drugs
Meds like Wegovy are all over the news. But are they right for you, especially if you're older than the average user?By Hallie LevineAre you wondering whether you’re a candidate for one of the
Study finds bariatric surgery declined with rise in GLP-1 drugs to treat obesity
A new study has examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than doubled from 2022 to 2023.
Rolling Out22m
7 amazing things nobody tells you about semaglutide weight loss results
Looking to drop those stubborn pounds? The weight loss world is buzzing about a game-changing medication that's helping ...
Bariatric surgeries drop sharply as people turn to Wegovy, Saxenda for weight loss
The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...
Peninsula Daily News15h
GlucoBoost GLP-1 Booster: Reviewing The Natural Weight Loss Secret Doctors Won’t Tell You About
In a world increasingly focused on health and wellness, finding effective solutions for weight management can be challenging.
Rolling Out2h
7 crucial facts about Ozempic’s controversial rise in weight loss treatment
The increasing use of Ozempic for modest weight loss has sparked intense debate within medical communities, raising questions ...
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.